KennethWashburnMD

PubMed

• Effect of the opioid crisis on the liver transplantation donor pool: A national analysis.
  Yutaka Endo, Muhammad Musaab Munir, Selamawit Woldesenbet, Erryk Katayama, Jason Yang, Kazunari Sasaki, Diamantis I Tsilimigras, Ashley Limkemann, Austin Schenk, Kenne...> ;Clinical Transplantation. 2024 Apr 1
• Liver transplantation access and outcomes: Impact of variations in liver-specific specialty care.
  Yutaka Endo, Kazunari Sasaki, Zorays Moazzam, Selamawit Woldesenbet, Henrique A Lima, Laura Alaimo, Muhammad Musaab Munir, Jason Yang, Lovette Azap, Erryk Katayama, Mi...> ;Surgery. 2024 Mar 1
• Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies.
  Alexander H Shannon, Samantha M Ruff, Austin D Schenk, Kenneth Washburn, Timothy M Pawlik> ;Medicina. 2023 Jul 13
• Outcomes After Deceased Donor Kidney Transplantation Using Kidney Allografts With Marginal Perfusion Parameters.
  Pranit N Chotai, April Logan, Jayanthan Subramanian, Priyamvada Singh, Manjit Kaur, Guy Brock, Ashley Limkemann, Austin Schenk, Musab Alebrahim, Amer Rajab, Kenneth Wa...> ;Transplantation Proceedings. 2023 Sep 1
• 3 citations
  Quality of ChatGPT Responses to Questions Related To Liver Transplantation.
  Yutaka Endo, Kazunari Sasaki, Zorays Moazzam, Henrique A Lima, Austin Schenk, Ashley Limkemann, Kenneth Washburn, Timothy M Pawlik> ;Journal of Gastrointestinal Surgery. 2023 Aug 1
• 1 citations
  Patients are pragmatic and physicians are perfectionists? Comparing success after liver transplantation among patients and physicians.
  Ingrid Woelfel, Daria Faulkner, Sandra Wong, Kenneth Washburn, Austin Schenk> ;Liver Transplantation. 2023 Apr 1
• 10 citations
  American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement.
  Kristopher P Croome, Andrew S Barbas, Bryan Whitson, Ali Zarrinpar, Timucin Taner, Denise Lo, Malcolm MacConmara, Jim Kim, Peter T Kennealey, Jonathan S Bromberg, Kenn...> ;American Journal of Transplantation. 2023 Feb 1
• 1 citations
  Kidney transplant from hepatitis C viremic donors into aviremic recipients and risk for post-transplant BK and cytomegalovirus infection.
  Reem Daloul, Kendra Schnelle, Lauren Von Stein, April Logan, Priyamvada Singh, Priya Yenebere, Todd Pesavento, Kenneth Washburn> ;Transplant Infectious Disease. 2022 Aug 1
• 1 citations
  Safely Expanding the Liver Donor Pool by Utilization of Organs from Donation after Circulatory Death with Comparable Results to Donation After Brain Death, a Large Sin...
  Ashley J Limkemann, Navdeep Singh, Austin Schenk, April Logan, Laura Washburn, Musab Alebrahim, Sylvester M Black, Ashraf El-Hinnawi, Ken Washburn, Helfrich, K.> ;Journal of Gastrointestinal Surgery. 2022 Jul 1
• 14 citations
  Dynamic impact of liver allocation policy change on donor utilization.
  Ethan Chan, April J Logan, Jeffrey M Sneddon, Navdeep Singh, Guy N Brock, William K Washburn, Austin D Schenk> ;American Journal of Transplantation. 2022 Jul 1
• 3 citations
  Textbook Outcome as a Quality Metric in Liver Transplantation.
  Austin D Schenk, Jing L Han, April J Logan, Jeffrey M Sneddon, Guy N Brock, Timothy M Pawlik, William K Washburn> ;Transplantation Direct. 2022 May 1
• Spinal Stroke following Kidney Transplant.
  Jayanthan B Subramanian, Farjad Siddiqui, Pranit N Chotai, Yazan Al-Adwan, Amer Rajab, Kenneth Washburn, Austin D Schenk, Ashley J Limkemann, Michael Luttrull, Musab A...> ;Case Reports in Transplantation. 2022 Jan 1
• 1 citations
  Trends and Health Care Outcomes Among Living Liver Donors: Are We Ready to Expand the Donor Pool With Living Liver Donations?
  Sajid Jalil, Sylvester M. Black, Kenneth Washburn, Neil Rangwani, Alice Hinton, Sean G. Kelly, Lanla Conteh, James Hanje, Anthony Michaels, Khalid Mumtaz> ;Liver Transplantation. 2021 Nov 1
• 10 citations
  Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
  Lindsay A. Sobotka, Khalid Mumtaz, Michael R. Wellner, Sean G. Kelly, Lanla Conteh, A. James Hanje, Austin Schenk, Ashraf El-Hinnawi, Sylvester M. Black, Kenneth Washb...> ;Annals of Hepatology. 2021 Sep 1
• 6 citations
  Machine perfusion of kidney allografts affects early but not late graft function.
  Navdeep Singh, April Logan, Austin Schenk, Ginny L. Bumgardner, Guy Brock, Ashraf El-Hinnawi, Amer Rajab, Kenneth Washburn> ;American Journal of Surgery. 2021 Jul 6
• 2 citations
  A real-world, single-center experience of the utilization of hepatitis C-viremic kidneys for hepatitis C-negative recipients.
  Reem Daloul, Michaels Anthony, Kenneth Washburn, Priyamvada Singh, Todd E. Pesavento> ;Clinical Nephrology. 2021 Jun 25
• 2 citations
  Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test.
  Devalingam Mahalingam, Leonidas Chelis, Imran Nizamuddin, Sunyoung S. Lee, Stylianos Kakolyris, Glenn A. Halff, Kenneth Washburn, Kristopher Attwood, Ibnshamsah Fahad,...> ;Cancers. 2021 Jun 22
• Donation After Circulatory Death Yields Survival Rates Similar to Donation After Brain Death Liver Transplant, Which Effectively Expands the Donor Pool.
  Navdeep Singh, Katelynn Helfrich, Khalid Mumtaz, Kenneth Washburn, April Logan, Sylvester M. Black, Austin Schenk, Ashley Limkemann, Musab Alebrahim, Ashraf El-Hinnawi> ;Experimental and Clinical Transplantation. 2021 Apr 16
• 2 citations
  Left Renal Vein Ligation for Spontaneous Splenorenal Shunts During Deceased-Donor Orthotopic Liver Transplant Is Safe and Can Mitigate Complications from Portal Steal:...
  Michelle C. Nguyen, Latifah Sage Silski, Musab Alebrahim, Sylvester M. Black, Elmahdi A. Elkhammas, Kenneth Washburn, Ashraf El-Hinnawi> ;Experimental and Clinical Transplantation. 2021 Apr 1
• 1 citations
  Congenital Absence of the Portal Vein.
  Eliza W. Beal, Kirstin Foley, Kenneth Washburn, Allan Tsung> ;The American Surgeon. 2020 Dec 9
• 3 citations
  Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis.
  Khalid Mumtaz, Jannel Lee-Allen, Kyle Porter, Sean G. Kelly, James Hanje, Lanla Conteh, Anthony Michaels, Ashraf El-Hinnawi, Kenneth Washburn, Sylvester M. Black, Marw...> ;Scientific Reports. 2020 Nov 6
• 3 citations
  The impact of donor and recipient diabetes on renal transplant outcomes
  Navdeep Singh, Kenneth Washburn, Austin Schenk, Ashraf El-Hinnawi, Ginny L. Bumgardner, April Logan, Amer Rajab> ;Clinical Transplantation. 2020 Oct 13
• 4 citations
  Techniques for Management of Portal Vein Thrombosis during Liver Transplantation.
  Navdeep Singh, Kenneth Washburn, Sylvester M. Black, Austin Schenk> ;Case Reports in Transplantation. 2020 Aug 28
• 2 citations
  Sequential Versus Combined Heart–Liver Transplantation in the USA
  Yoshikazu Yamaguchi, Candice Burrier, Catherine Roth, Dmitry Tumin, Eliza W. Beal, Kenneth Washburn, Don Hayes, Joseph D. Tobias> ;Digestive Diseases and Sciences. 2020 Aug 1
• Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
  Eliza W. Beal, Clifford Akateh, Dmitry Tumin, Fabio Bagante, Sylvester M. Black, Kenneth Washburn, Daniel Azouley, Timothy M. Pawlik> ;Experimental and Clinical Transplantation. 2020 Aug 1
• Join now to see all

Journal Articles

• Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): Phase II trial of stable liver transplant recipients  
  Alloway R, Eckhoff DE, Washburn WK, Teperman LW, Liver Transpl, 1/1/2014
• TGF-Beta signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells  
  Mu X, Lin S, Yang J, Chen C, Herzig MC, Washburn WK, Halff GA, Walter CA, Sun B, Sun L, Plos One, 1/1/2013
• Truth and consequences: the challenge of greater transparency in liver distribution and utilization  
  Washburn K, Olthoff K, Am J Transplant, 1/1/2012
• Maximizing donor potential: Evolving organ procurement organization metrics and optimizing organ distribution and allocation in the United States  
  Washburn WK, Liver Transpl, 1/1/2012
• Model for end-stage liver disease exceptions: Proceed with caution  
  Washburn WK, Liver Transpl, 1/1/2011
• A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C  
  Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron..., Liver Transpl, 1/1/2011
• Liver allocation and distribution: possible next steps  
  Washburn K, Pomfret E, Roberts J, Washburn WK, Liver Transpl, 1/1/2011
• Hepatocellular carcinoma and liver transplantation  
  Washburn K, Halff G, Washburn WK, Curr Opin Organ Transplant, 1/1/2011
• Sirolimus Plus Sorafenib in Treating HCC Recurrence after Liver Transplantation: A Case Report  
  Halff GA, Wang Y, Speeg KV, Washburn WK, World Journal of Gastroenterology, 1/1/2010
• Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system  
  Washburn K, Edwards E, Harper A, Freeman R, Washburn WK, Am J Transplant, 1/1/2010
• Argon gas embolism with the use of argon beam coagulation during open hepatic resection  
  A. Cornejo, Liao LF, Washburn WK, The Internet Journal of Surgery, 1/1/2010
• Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States  
  Pomfret EA, Washburn K, Wald C, Nalesnik MA, Douglas D, Russo M, Roberts J, Reich DJ, Schwartz ME, Mieles L, Lee FT, Florman S, Yao F, Harper A, Edwards E, Freeman R, ..., Liver Transpl, 1/1/2010
• Model for End Stage Liver Disease and hepatocellular carcinoma: a moving target  
  Washburn K, Transplant Rev, 1/1/2010
• Geography, transplant centers, and recipients: What can we learn?  
  Washburn WK, Liver Transpl, 1/1/2008
• Geography, Transplant Centers and Recipients: What can we learn?  
  Washburn WK, Liver Transpl, 1/1/2007
• An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance  
  Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR, Washburn WK, Liver Transpl, 1/1/2007
• The Pan-caspase Inhibitor, IDN-6556, Reduces Human Liver Preservation Injury  
  E S Baskin-Bey, Washburn WK, S Feng, T Oltersdorf, D Shapiro, M Huyghe, L Burgart, M Garrity-Park, F G I van Vilsteren, LK Oliver, C B Rosen, G J Gores, Am J Transplant, 1/1/2007
• Regional sharing for adult status 1 candidates: Reduction in waitlist mortality  
  Washburn K, Harper A, Klintmalm G, Goss J, Halff G, Liver Transpl, 1/1/2006
• Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients  
  Wiltshire H, Paya CARLOS, Pescovitz MARK, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Zuideveld KLAAS, Washburn WK, Transplantation, 1/1/2005
• Multicenter Piolt Study of Early (4day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus, and Sirolimus  
  Woodle ES, Vincenti F., Lorber M., Gritsch A., Hricik D., Washburn W.K., Matas A, Gallichio M., Neylan J.A., Am J Transplant, 1/1/2005
• Pharmacokinetic Profile of Ganciclovir After its Oral Aministration and From its Prodrug, Valganciclovir, in Solid ORgan Transplant Recipients  
  Wiltshire, H, Hirankarn, S, Farrell, C, Paya, C, Pescovitz, M, Humar, A, Dominquez, E, Washburn WK, Blumberg, E, Alexander, B, Freeman, R, Heaton, N, Clinical Pharmacokinetics, 1/1/2005
• UTHSCSA and Liver, Kidney and Pancreas Transplantation  
  Esterl RM, Washburn WK, Halff GA, San Antonio Medicine, 1/1/2005
• Risk Factors for Cytomegalovirus Viremia and Disease Developing after Prophylaxis in High-Risk Solid-Organ Transplant Recipients  
  Freeman RICHARD, Paya C, Pescovitz MARK, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Heaton N, Washburn WK, Transplantation, 1/1/2004
• Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients  
  Boivin G, Goyette N, Gilbert C, Roberts N, Macey K, Paya C, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Covington E, ..., J Infect Dis, 1/1/2004
• Efficacy and safety of once-daily oral valganciclovir vs oral ganciclovir three times daily for the prevention of cytomegalovirus disease in solid organ transplant rec...  
  Paya C., Humar A., Dominguez E.,Washburn W.K., Alexander B., Blumberg E., Freeman R., Heaton N., Macey K., Tansley R., Pescovitz M., Am J Transplant, 1/1/2004
• Join now to see all

Books/Book Chapters

• Transplantation of the Liver 
  Chapter: U.S. Trends in Transplantation: 1988-Present 
  Washburn WKElsevier2014
• Piggyback Liver Transplant 
  Chapter: Operative Techniques in Transplant Surgery 
  Almeda JA, Washburn WKWolters Kluwer Health/Lippincott Williams & Wilkins2014
• Essential Emergency Medicine for the Healthcare Practitioner 
  Chapter: Liver Transplantation 
  Espinoza A, Speeg KV, Washburn K, Halff GEditors: Espinoza A, Speeg, Washburn K, Halff G.Saunders-Elsevier2007
• Vascular Access for Hemodialysis VII 
  Chapter: Ischemic Monomelic Neuropathy as a Complication of Forearm PTFE Loop Grafts in Uremic Diabetic Patients 
  Raheb J, Esterl RM, Washburn WK, Cigarroa FG, Halff GAEditors: Henry ML.WL Gore and Access Medical Group, Ltd.2001
• Vascular Access for Hemodialysis VII 
  Chapter: A Revisited Technique to Salvage Failed End to Side Radiocephalic Fistulae for Chronic Hemodialysis 
  Raheb J, Esterl RM, Washburn WK, Cigarroa FG, Halff GAEditors: Henry ML.WL Gore and Access Medical Group, Ltd.2001
• Join now to see all

Abstracts/Posters

• Risk Factors for Number and Severity of Complications Following Deceased Donor Liver Transplantation
  Parikh A, Washburn WK, Matsuoka L, Pandit U, Genyk Y, Almeda JL, Mora-Esteves C, Halff GA, Kim J, Holland B, Wilson D, Sher L, Koneru B, Liver Transplantation, 1/1/2014
• Multi-OPO Case Control Study of Safety and Liver Utilization With Pre-Recovery Liver Biopsy
  Oliver J, Machineni P, Bongu A, Nespral J, Kadric C, Goldstein M, Lerner H, Dikdan G, Brown L, Washburn WK, Koneru B, American Journal of Transplantation, 1/1/2014
• Decellularized Liver Matrix Proteins on Porcine Hepatocytes in vitro
  Washburn, WK, Biomedical Engineering Society, San Antonio, TX, 1/1/2014
• TGF-Beta signaling is frequently downregulated in hepatocellular carcinoma, but is retained for malignant phenotype in some hepatocellular carcinoma cells
  Mu X, Herzig MC, Washburn WK, Walter CA, Halff GA, Sun L, AACR 103rd Annual Meeting, Chicago, IL, 1/1/2012
• High MELD/PELD Versus Status 1A: Who Lives, Who Dies, and When?
  Olthoff KM, Stock PG, Liu J, Peng Y, Kim WR, Washburn WK, Harper AM, Edwards E, Snyder JJ, Israni AK, Kasiske BL, American Journal of Transplantation, 1/1/2012
• A Phase II Open Label Multicenter Extension Study in Stable Liver Transplant Patients To Assess the Pharmacokinetic Profi le, Safety, and Tolerability of Once-Daily Ex...
  Washburn WK, Alloway RR, Eckhoff DE, Teperman LW, American Journal of Transplantation, 1/1/2012
• Dilated Cardiomyopathy After Orthotopic Liver Transplantation: A Multi-Institutional Report Of Six Cases Treated With Mechanical Assist Devices
  Nguyen N, Ha CP, Harring TR, Chu D, Kar B, O’Mahony C, Bakaeen F, Speeg KV, Washburn WK, Halff GA, Goss JA, Hepatology, 1/1/2011
• Serum Sodium Concentration Remains An Important Determinant Of Waitlist Mortality: A Report From The Scientific Registry Of Transplant Recipients
  Kim WR, Biggins S, Stock P, Peng Y, Liu Y, Harper AM, Edwards EB, Washburn WK, Charlton M, Hepatology, 1/1/2011
• Regional Sharing Of Livers In Region 8 - Did It Work?
  Hirose R, Stock P, Washburn WK, Olthoff KM, Kim WR, Liu J, Peng Y, Snyder J, Kasiske BL, Hepatology, 1/1/2011
• Are Adult Candidates Needing a Combined Liver and Intestine Transplant Disadvantaged in the Liver Allocation System?
  Edwards E, Harper A, Sudan D, Washburn K, American Journal of Transplantation, 1/1/2011
• Reconstruction Technique for In Situ Split-Liver Transplantation
  O’Mahony CA, Harring TR, Nguyen TT, Sussman NL, Washburn WK, Halff GA, Goss JA, American Journal of Transplantation, 1/1/2011
• Results of a Survey of Transplant Center HCC Imaging Practices
  Heimbach JK, Harper AM, Marvin MR, Brown KA, Edwards EB, McCashland TM, Sudan DL, Trotter JF, Washburn WK, Teperman LW, American Journal of Transplantation, 1/1/2011
• Predicted Impact of Changes to Deceased-Donor Liver Allocation System on Patient Survival and Distance Traveled
  Schaubel DE, Guidinger MK, Rodgers AM, Roberts JP, Washburn WK, Merion RM, American Journal of Transplantation, 1/1/2010
• Broader Liver Sharing in Region 8: A Two-Year Experiment
  Edwards E, Taranto S, Solomon H, Washburn K, American Journal of Transplantation, 1/1/2010
• Transplant free survival (TFS) after Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation with the Viatorr covered-stent
  Cura M, El-Merhi F, Suri R, Lopera JE, Speeg KV, Guerrero JA, Washburn WK, Halff GA, Cardiovascular and Interventional Radiological Society of Europe, 1/1/2010
• Transjugular intrahepatic portosystemic shunts (TIPS) creation in recurrent hepatitis C (HCV) cirrhosis after Liver Transplantation (LT)
  Cura M, Speeg KV, El-Merhi F, Suri R, Lopera JE, Washburn WK, Halff GA, Cardiovascular and Interventional Radiology Society of Europe, 1/1/2010
• Are HCC Candidates Advantaged in the Liver Allocation System?
  Washburn WK, Edwards E, Harper A, Freeman R, American Transplant Congress; American Journal of Transplantation, Boston, MA, 1/1/2009
• An Early Regional Experience with Expansion of Milan Criteria for Liver Transplant Recipients
  Washburn WK, Harper A, Goss J, Mieles L, Sebastian A, Cheng S, Klintmalm G, American Transplant Congress; American Journal of Transplantation, Boston, MA, 1/1/2009
• Hepatitis C(Hcv)-3 Study: Severe Hcv Recurrence (R) Post Liver Transplantation (Olt) Is Decreased In Patients Treated With Mycophenolate Mofetil (Mmf), Particularly, I...
  Klintmalm GB, Fasola CG, Jennings L, Heffron TG, Sher L, Mulligan D, Brown R, Ham J, Teperman L, Rudich S, Eckhoff D, Washburn K, Millis M, Roberts J, Charlton M, Bali..., Hepatology, 1/1/2008
• Hepatitis C (HCV)- 3 Study: Benefits of a Steroid-Free Immunosuppression (IS) Regimen in HCV-Infected Liver Transplant Recipients (OLT) May Become Evident Only after L...
  Klintmalm GB, Fasola CG, Jennings L, Heffron TG, Sher L, Mulligan D, Brown R, Ham J, Teperman L, Rudich S, Eckhoff D, Washburn K, Millis M, Roberts J, Charlton M, Bali..., Hepatology, 1/1/2008
• Survival of Adult Recipients of Right Lobe Liver from a Split: An Analysis of the OPTN Database
  Cherikh WS, Washburn K, Cheng Y, Horslen S, American Journal of Transplantation, 1/1/2008
• Factors Influencing Liver Transplant Length Of Stay And Resource Utilization At Two Large Volume Transplant Centers
  Feng S, Roberts J, Halff G, Washburn K, Hepatology, 1/1/2007
• Hepatitis C (Hcv)- 3 Study: Does Immunosuppression (Is) Affect The Progression Of Fibrosis Of Hcv Recurrence After Liver Transplantation (Olt)?
  Klintmalm GB, Fasola CG, Jennings L, Heffron TG, Sher L, Mulligan D, Brown R, Ham J, Teperman L, Rudich S, Eckhoff D, Washburn K, Millis M, Roberts J, Charlton M, Bali..., Hepatology, 1/1/2007
• The Pan-Caspase Inhibitor, Idn-6556, Attenuates Human Liver Preservation Injury
  Bey E, Washburn K, Feng S, Oltersdorf T, Shapiro D, Burgart L, Garrity-Park M, GI van Vilsteren F, Oliver L, Rosen C, Gores G, Hepatology, 1/1/2006
• Multicenter Randomized Hepatitis C (Hcv) - Three Trial Post Liver Transplantation (Olt): Two-Year Interim Report
  Fasola C, Heffron T, Sher L, Douglas D, Brown R, Ham J, TepermanL, Hanaway M, Eckhoff D, Washburn K, Millis M, Roberts J, Charlton M, Baliga P, Pruett T , Koneru B, Po..., Hepatology, 1/1/2006
• Join now to see all

Lectures

• Liver Allocation Update 
  San Antonio, TX - 1/1/2014
• Quality Metrics and Assessment;Lessons from Liver Transplantation 
  Columbus, OH - 1/1/2013
• Decellularized Extracellular Matrix Based Hydrogels for Liver Repair and Regeneration 
  Boston, MA - 1/1/2013
• Maximizing Donor Potential; Evolving OPO Metrics and Optimizing Organ Distribution and Allocation in the U.S. 
  Boston, MA - 1/1/2012
• Keeping Patients Within UNOS Criteria 
  Boston, MA - 1/1/2012
• What Every Transplant Fellowship Curriculum Should Have 
  Miami, FL - 1/1/2012
• Downstaging for Milan Criteria 
  San Francisco, CA - 1/1/2011
• Net Benefit Liver Allocation 
  Valencia, Spain - 1/1/2011
• The Role of Resection and Transplant for HCC 
  Philadelphia, PA - 1/1/2011
• HCC-Allocation and the Role of the Living Donor 
  Miami Beach, FL - 1/1/2011
• MELD Update 
  Rochester, MN - 1/1/2010
• Allocation for HCC 
  San Diego, CA - 1/1/2010
• UNOS Forum on Liver Allocation 
  Atlanta, GA - 1/1/2010
• MELD Where are we going 
  Worcester, MA - 1/1/2010
• HCC Patients are Advantage in the Liver Allocation Scheme 
  Boston, MA - 1/1/2009
• Are HCC Candidates Advantaged in the Liver Allocation System? 
  Boston, MA - 1/1/2009
• Immunosuppression and Liver Transplantation 
  Chengdu, China - 1/1/2005
• Who To Transplant 
  San Antonio, TX - 1/1/2005
• Steroid-Free Immunosuppression in Liver Transplantation 
  Los Angeles, CA - 1/1/2005
• Immunosuppression and HCV Recurrence in Liver Transplantation 
  Seattle, WA - 1/1/2005
• An Open Randomized, Prospective Multicenter Study to Compare the Efficacy and Safety Among Three Immunospressant Treatment Regimens in Patients Receiving a Liver for E... 
  Boston, MA - 1/1/2004
• Evaluation of the MELD/PELD System and Outcomes 
  San Antonio, TX - 1/1/2004
• Biliary and Vascular complications following Split Liver Transplantation 
  1/1/2004
• Valgancyciclovir for Prevention of CMV Disease: 12 Month Follow Up of a Randomized Trial of 364 D=/R- Transplant Recipients 
  1/1/2003
• Pharmacodynamics of Safety and efficacy for ganciclovir After its Oral Adminsitration and from its Pro-Drug, Valganciclovir, in Solid Organ Transplant Recipients 
  1/1/2003
• Join now to see all